The abstract is read at the publisher; the summary is JClub's.
Hecogenin acetate is fungistatic against Candida albicans, Candida tropicalis, and Candida krusei, and at its highest concentration completely inhibits the yeast-to-hyphae switch.
- Why it matters: Invasive Candida infections in immunocompromised patients face toxicity, recurrence, and resistance with current antifungals, motivating new agents that also target virulence transitions.
- What they did: Using broth microdilution and microculture, the study tested susceptibility and fluconazole combinations, then assessed morphological yeast-to-filament switching in Candida albicans, C. tropicalis, and C. krusei.
- The result: Hecogenin acetate had higher IC₅₀ than fluconazole and showed weaker growth inhibition in comparison, but it completely blocked yeast–hyphae switching at the highest concentration.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.